Lv5
1090 积分 2024-01-26 加入
Trends in the drug target landscape for autoimmune diseases
4天前
已完结
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
4天前
已完结
Role of thymic stromal lymphopoietin in allergy and beyond
16天前
已完结
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
16天前
已完结
A phase 2a trial of the IL-33 mAb tozorakimab in patients with COPD: FRONTIER-4
17天前
已关闭
The Breathlessness, Cough, and Sputum Scale: The Development of Empirically Based Guidelines for Interpretation
17天前
已完结
Chronic obstructive pulmonary disease
29天前
已完结
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
1个月前
已完结
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
1个月前
已完结
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
1个月前
已完结
皖公网安备34019202002308
